Chinese scientists achieve megabase-scale programmable chromosome engineering, enabling large-scale, precise DNA modifications without traces, marking a milestone in genome editing. Alongside, researchers develop an RNA molecule simultaneously silencing two key oncogenes, KRAS and MYC, opening transformative paths in cancer therapeutics. These developments position gene editing and RNA-based treatments as powerful tools for precision medicine.